A recent study shows that inflammation could be the underlying factor that determines the differences in metabolic profiles between subgroups of obesity. An improved understanding and characterization of these subgroups should help to develop innovative approaches to treat obesity.
This is a preview of subscription content
Access options
Subscribe to Journal
Get full journal access for 1 year
$59.00
only $4.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.
References
Karelis, A. D., St-Pierre, D. H., Conus, F., Rabasa-Lhoret, R. & Poehlman, E. T. Metabolic and body composition factors in subgroups of obesity: what do we know? J. Clin. Endocrinol. Metab. 89, 2569–2575 (2004).
Wildman, R. P. et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999–2004). Arch. Intern. Med. 168, 1617–1624 (2008).
Calori, G. et al. Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study. Diabetes Care 34, 210–215 (2011).
Hamer, M. & Stamatakis, E. Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality. J. Clin. Endocrinol. Metab. 97, 2482–2488 (2012).
Meigs, J. B. et al. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J. Clin. Endocrinol. Metab. 91, 2906–2912 (2006).
Phillips, C. M. & Perry, I. J. Does inflammation determine metabolic health status in obese and nonobese adults? J. Clin. Endocrinol. Metab. http://dx.doi.org/10.1210/jc.2013-2038.
Karelis, A. D. et al. The metabolically healthy but obese Individual presents a favourable inflammation profile. J. Clin. Endocrinol. Metab. 90, 4145–4150 (2005).
Shin, M. J. et al. Weight loss effect on inflammation and LDL oxidation in metabolically healthy but obese (MHO) individuals: low inflammation and LDL oxidation in MHO women. Int. J. Obes. (Lond.) 30, 1529–1534 (2006).
Primeau, V. et al. Characterizing the profile of obese patients who are metabolically healthy. Int. J. Obes. (Lond.) 35, 971–981 (2011).
Velho, S., Paccaud, F., Waeber, G., Vollenweider, P. & Marques-Vidal, P. Metabolically healthy obesity: different prevalences using different criteria. Eur. J. Clin. Nutr. 64, 1043–1051 (2010).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Karelis, A., Rabasa-Lhoret, R. Can inflammatory status define metabolic health?. Nat Rev Endocrinol 9, 694–695 (2013). https://doi.org/10.1038/nrendo.2013.198
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrendo.2013.198
Further reading
-
Metabolically healthy obesity and metabolically obese normal weight: a review
Journal of Physiology and Biochemistry (2021)
-
Comparing an adiposopathy approach with four popular classifications schemes to categorize the metabolic profile of postmenopausal women
Journal of Physiology and Biochemistry (2020)
-
Longitudinal micro-ultrasound assessment of the ob/ob mouse model: evaluation of cardiovascular, renal and hepatic parameters
International Journal of Obesity (2018)